Oric Pharmaceuticals, Inc. Annual Operating Income (Loss) in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Oric Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2023.
  • Oric Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$38.3M, a 33.6% decline year-over-year.
  • Oric Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$135M, a 32.8% decline year-over-year.
  • Oric Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$111M, a 20.7% decline from 2022.
  • Oric Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$91.8M, a 16.4% decline from 2021.
  • Oric Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$78.9M, a 6.32% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$111M -$19M -20.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-11
2022 -$91.8M -$12.9M -16.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-11
2021 -$78.9M -$4.69M -6.32% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 -$74.2M -$45.6M -160% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-21
2019 -$28.6M -$6.2M -27.7% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-21
2018 -$22.4M Jan 1, 2018 Dec 31, 2018 10-K 2021-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.